| 摘要 |
<p>The present invention relates to a physical form of the known drug substance glyburide, also known as glibenclamide, and chemically defined as 5chloroN[2[4[[[(cyclcohexylamino)carbonyl]amino]sulfonyl]p henyl]ethyl]2methoxybenzamide (Merck Index, Tenth Edition, p.642), as well as to dosage forms, e.g., tablets and capsules, incorporating said physical form of glyburide.</p> |
